Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the Latest Research Report,, the global market for HMGB1 Antibody should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
Growing patient base, launch of novel HMGB1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in revenue of the HMGB1 antibody market.
HMGB1 Antibody can be used in a variety of scientific applications, including western blotting, immunohistochemistry, immunocytochemistry, immunoprecipitation, and ELISA. These antibodies target MMP13 in human, mouse, rat, rabbit and pig samples.
This report aims to provide a comprehensive study of the global market for HMGB1 Antibody.
Key Highlights of the Report
(1) Global HMGB1 Antibody market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global HMGB1 Antibody market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China HMGB1 Antibody market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global HMGB1 Antibody segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global HMGB1 Antibody segment by type and by application and regional segment by type and by application.
(6) Global major production regions of HMGB1 Antibody, capacity, production and trends.
(7) HMGB1 Antibody industry supply chain, upstream, midstream and downstream analysis.
Key Regions Covered in This Report Are:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Monoclonal
Polyclonal
Market segment by application, can be divided into
Immunochemistry (IHC)
Immunofluorescence (IF)
Western Blot (WB)
Immunocytochemistry (ICC)
ELISA
Others
Market segment by players, this report covers
Merck
Thermo Fisher Scientific
Novus Biologicals
Abbexa
LifeSpan BioSciences
GeneTex
Bio-Rad
Bioss
Chondrex
Biorbyt
Abnova Corporation
Abeomics
Abcam
RayBiotech
EpiGentek
NSJ Bioreagents
ProSci
BioLegend
HUABIO
Elabscience Biotechnology
Enzo Life Sciences
AssayPro
Cell Signaling Technology
R and D Systems
Aviva Systems Biology
Beijing Solarbio
Jingjie PTM BioLab
1 Market Overview
1.1 HMGB1 Antibody Definition
1.2 Global HMGB1 Antibody Market Size and Forecast
1.2.1 By Revenue, Global HMGB1 Antibody Market Size, 2018-2029
1.2.2 By Sales Volume, Global HMGB1 Antibody Market Size, 2018-2029
1.2.3 Global HMGB1 Antibody Price Trend, 2018-2029
1.3 China HMGB1 Antibody Market Size and Forecast
1.3.1 By Revenue, China HMGB1 Antibody Market Size, 2018-2029
1.3.2 By Sales Volume, China HMGB1 Antibody Market Size, 2018-2029
1.3.3 China HMGB1 Antibody Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China HMGB1 Antibody Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China HMGB1 Antibody Share in Global Market, 2018-2029
1.4.3 HMGB1 Antibody Market Size: China VS Global, 2018-2029
1.5 HMGB1 Antibody Market Dynamics
1.5.1 HMGB1 Antibody Market Drivers
1.5.2 HMGB1 Antibody Market Restraints
1.5.3 HMGB1 Antibody Industry Trends
1.5.4 HMGB1 Antibody Industry Policy
2 Global Competitive Landscape by Company
2.1 Global HMGB1 Antibody Revenue by Company, 2018-2023
2.2 Global HMGB1 Antibody Sales Volume by Company, 2018-2023
2.3 Global HMGB1 Antibody Price by Company, 2018-2023
2.4 Global HMGB1 Antibody Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global HMGB1 Antibody Concentration Ratio
2.6 Global HMGB1 Antibody Mergers & Acquisitions, Expansion Plans
2.7 Global HMGB1 Antibody Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China HMGB1 Antibody Revenue by Company, 2018-2023
3.2 China HMGB1 Antibody Sales Volume by Company, 2018-2023
3.3 China HMGB1 Antibody HMGB1 Antibody Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China HMGB1 Antibody Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, HMGB1 Antibody Domestic VS Export
3.6 China Market, HMGB1 Antibody Import & Export
3.6.1 China Market, HMGB1 Antibody Import & Export, 2018-2029
3.6.2 China HMGB1 Antibody Import & Export Trends
3.6.3 Main Sources of China HMGB1 Antibody Import
3.6.4 Export Destination of China HMGB1 Antibody
4 HMGB1 Antibody Production by Region
4.1 Global HMGB1 Antibody Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of HMGB1 Antibody Manufacturers
4.3 Global Major Manufacturers, HMGB1 Antibody Capacity Expansion and Future Plans
4.4 Global HMGB1 Antibody Capacity by Region
4.5 Global HMGB1 Antibody Production by Region
4.5.1 Global HMGB1 Antibody Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global HMGB1 Antibody Production by Region, 2018-2023
4.5.3 Global HMGB1 Antibody Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 HMGB1 Antibody Industry Chain
5.2 HMGB1 Antibody Upstream Analysis
5.2.1 HMGB1 Antibody Core Raw Materials
5.2.2 Main Manufacturers of HMGB1 Antibody Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 HMGB1 Antibody Production Mode
5.6 HMGB1 Antibody Procurement Model
5.7 HMGB1 Antibody Industry Sales Model and Sales Channels
5.7.1 HMGB1 Antibody Sales Model
5.7.2 HMGB1 Antibody Typical Distributors
6 Sights by Type
6.1 HMGB1 Antibody Classification
6.1.1 Monoclonal
6.1.2 Polyclonal
6.2 By Type, Global HMGB1 Antibody Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global HMGB1 Antibody Revenue, 2018-2029
6.4 By Type, Global HMGB1 Antibody Sales Volume, 2018-2029
6.5 By Type, Global HMGB1 Antibody Price, 2018-2029
7 Sights by Application
7.1 HMGB1 Antibody Segment by Application
7.1.1 Immunochemistry (IHC)
7.1.2 Immunofluorescence (IF)
7.1.3 Western Blot (WB)
7.1.4 Immunocytochemistry (ICC)
7.1.5 ELISA
7.1.6 Others
7.2 By Application, Global HMGB1 Antibody Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global HMGB1 Antibody Revenue, 2018-2029
7.4 By Application, Global HMGB1 Antibody Sales Volume, 2018-2029
7.5 By Application, Global HMGB1 Antibody Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global HMGB1 Antibody Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global HMGB1 Antibody Revenue, 2018-2029
8.3 By Region, Global HMGB1 Antibody Sales Volume, 2018-2029
8.4 North America
8.4.1 North America HMGB1 Antibody Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America HMGB1 Antibody Market Size Market Share
8.5 Europe
8.5.1 Europe HMGB1 Antibody Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe HMGB1 Antibody Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific HMGB1 Antibody Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific HMGB1 Antibody Market Size Market Share
8.7 South America
8.7.1 South America HMGB1 Antibody Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America HMGB1 Antibody Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global HMGB1 Antibody Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global HMGB1 Antibody Revenue, 2018-2029
9.3 By Country, Global HMGB1 Antibody Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. HMGB1 Antibody Market Size, 2018-2029
9.4.2 By Company, U.S. HMGB1 Antibody Sales Volume Market Share, 2022
9.4.3 By Type, U.S. HMGB1 Antibody Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. HMGB1 Antibody Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe HMGB1 Antibody Market Size, 2018-2029
9.5.2 By Company, Europe HMGB1 Antibody Sales Volume Market Share, 2022
9.5.3 By Type, Europe HMGB1 Antibody Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe HMGB1 Antibody Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China HMGB1 Antibody Market Size, 2018-2029
9.6.2 By Company, China HMGB1 Antibody Sales Volume Market Share, 2022
9.6.3 By Type, China HMGB1 Antibody Market Size, Share, 2022 VS 2029
9.6.4 By Application, China HMGB1 Antibody Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan HMGB1 Antibody Market Size, 2018-2029
9.7.2 By Company, Japan HMGB1 Antibody Sales Volume Market Share, 2022
9.7.3 By Type, Japan HMGB1 Antibody Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan HMGB1 Antibody Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea HMGB1 Antibody Market Size, 2018-2029
9.8.2 By Company, South Korea HMGB1 Antibody Sales Volume Market Share, 2022
9.8.3 By Type, South Korea HMGB1 Antibody Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea HMGB1 Antibody Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia HMGB1 Antibody Market Size, 2018-2029
9.9.2 By Company, Southeast Asia HMGB1 Antibody Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia HMGB1 Antibody Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia HMGB1 Antibody Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India HMGB1 Antibody Market Size, 2018-2029
9.10.2 By Company, India HMGB1 Antibody Sales Volume Market Share, 2022
9.10.3 By Type, India HMGB1 Antibody Market Size, Share, 2022 VS 2029
9.10.4 By Application, India HMGB1 Antibody Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia HMGB1 Antibody Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia HMGB1 Antibody Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia HMGB1 Antibody Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia HMGB1 Antibody Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Merck
10.1.1 Merck Company Information, Head Office, Market Area and Industry Position
10.1.2 Merck HMGB1 Antibody Models, Specifications and Application
10.1.3 Merck HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Merck Company Profile and Main Business
10.1.5 Merck Recent Developments
10.2 Thermo Fisher Scientific
10.2.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
10.2.2 Thermo Fisher Scientific HMGB1 Antibody Models, Specifications and Application
10.2.3 Thermo Fisher Scientific HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Thermo Fisher Scientific Company Profile and Main Business
10.2.5 Thermo Fisher Scientific Recent Developments
10.3 Novus Biologicals
10.3.1 Novus Biologicals Company Information, Head Office, Market Area and Industry Position
10.3.2 Novus Biologicals HMGB1 Antibody Models, Specifications and Application
10.3.3 Novus Biologicals HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Novus Biologicals Company Profile and Main Business
10.3.5 Novus Biologicals Recent Developments
10.4 Abbexa
10.4.1 Abbexa Company Information, Head Office, Market Area and Industry Position
10.4.2 Abbexa HMGB1 Antibody Models, Specifications and Application
10.4.3 Abbexa HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Abbexa Company Profile and Main Business
10.4.5 Abbexa Recent Developments
10.5 LifeSpan BioSciences
10.5.1 LifeSpan BioSciences Company Information, Head Office, Market Area and Industry Position
10.5.2 LifeSpan BioSciences HMGB1 Antibody Models, Specifications and Application
10.5.3 LifeSpan BioSciences HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 LifeSpan BioSciences Company Profile and Main Business
10.5.5 LifeSpan BioSciences Recent Developments
10.6 GeneTex
10.6.1 GeneTex Company Information, Head Office, Market Area and Industry Position
10.6.2 GeneTex HMGB1 Antibody Models, Specifications and Application
10.6.3 GeneTex HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 GeneTex Company Profile and Main Business
10.6.5 GeneTex Recent Developments
10.7 Bio-Rad
10.7.1 Bio-Rad Company Information, Head Office, Market Area and Industry Position
10.7.2 Bio-Rad HMGB1 Antibody Models, Specifications and Application
10.7.3 Bio-Rad HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Bio-Rad Company Profile and Main Business
10.7.5 Bio-Rad Recent Developments
10.8 Bioss
10.8.1 Bioss Company Information, Head Office, Market Area and Industry Position
10.8.2 Bioss HMGB1 Antibody Models, Specifications and Application
10.8.3 Bioss HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Bioss Company Profile and Main Business
10.8.5 Bioss Recent Developments
10.9 Chondrex
10.9.1 Chondrex Company Information, Head Office, Market Area and Industry Position
10.9.2 Chondrex HMGB1 Antibody Models, Specifications and Application
10.9.3 Chondrex HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Chondrex Company Profile and Main Business
10.9.5 Chondrex Recent Developments
10.10 Biorbyt
10.10.1 Biorbyt Company Information, Head Office, Market Area and Industry Position
10.10.2 Biorbyt HMGB1 Antibody Models, Specifications and Application
10.10.3 Biorbyt HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Biorbyt Company Profile and Main Business
10.10.5 Biorbyt Recent Developments
10.11 Abnova Corporation
10.11.1 Abnova Corporation Company Information, Head Office, Market Area and Industry Position
10.11.2 Abnova Corporation HMGB1 Antibody Models, Specifications and Application
10.11.3 Abnova Corporation HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Abnova Corporation Company Profile and Main Business
10.11.5 Abnova Corporation Recent Developments
10.12 Abeomics
10.12.1 Abeomics Company Information, Head Office, Market Area and Industry Position
10.12.2 Abeomics HMGB1 Antibody Models, Specifications and Application
10.12.3 Abeomics HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Abeomics Company Profile and Main Business
10.12.5 Abeomics Recent Developments
10.13 Abcam
10.13.1 Abcam Company Information, Head Office, Market Area and Industry Position
10.13.2 Abcam HMGB1 Antibody Models, Specifications and Application
10.13.3 Abcam HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Abcam Company Profile and Main Business
10.13.5 Abcam Recent Developments
10.14 RayBiotech
10.14.1 RayBiotech Company Information, Head Office, Market Area and Industry Position
10.14.2 RayBiotech HMGB1 Antibody Models, Specifications and Application
10.14.3 RayBiotech HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 RayBiotech Company Profile and Main Business
10.14.5 RayBiotech Recent Developments
10.15 EpiGentek
10.15.1 EpiGentek Company Information, Head Office, Market Area and Industry Position
10.15.2 EpiGentek HMGB1 Antibody Models, Specifications and Application
10.15.3 EpiGentek HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 EpiGentek Company Profile and Main Business
10.15.5 EpiGentek Recent Developments
10.16 NSJ Bioreagents
10.16.1 NSJ Bioreagents Company Information, Head Office, Market Area and Industry Position
10.16.2 NSJ Bioreagents HMGB1 Antibody Models, Specifications and Application
10.16.3 NSJ Bioreagents HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 NSJ Bioreagents Company Profile and Main Business
10.16.5 NSJ Bioreagents Recent Developments
10.17 ProSci
10.17.1 ProSci Company Information, Head Office, Market Area and Industry Position
10.17.2 ProSci HMGB1 Antibody Models, Specifications and Application
10.17.3 ProSci HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.17.4 ProSci Company Profile and Main Business
10.17.5 ProSci Recent Developments
10.18 BioLegend
10.18.1 BioLegend Company Information, Head Office, Market Area and Industry Position
10.18.2 BioLegend HMGB1 Antibody Models, Specifications and Application
10.18.3 BioLegend HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.18.4 BioLegend Company Profile and Main Business
10.18.5 BioLegend Recent Developments
10.19 HUABIO
10.19.1 HUABIO Company Information, Head Office, Market Area and Industry Position
10.19.2 HUABIO HMGB1 Antibody Models, Specifications and Application
10.19.3 HUABIO HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.19.4 HUABIO Company Profile and Main Business
10.19.5 HUABIO Recent Developments
10.20 Elabscience Biotechnology
10.20.1 Elabscience Biotechnology Company Information, Head Office, Market Area and Industry Position
10.20.2 Elabscience Biotechnology HMGB1 Antibody Models, Specifications and Application
10.20.3 Elabscience Biotechnology HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.20.4 Elabscience Biotechnology Company Profile and Main Business
10.20.5 Elabscience Biotechnology Recent Developments
10.21 Enzo Life Sciences
10.21.1 Enzo Life Sciences Company Information, Head Office, Market Area and Industry Position
10.21.2 Enzo Life Sciences HMGB1 Antibody Models, Specifications and Application
10.21.3 Enzo Life Sciences HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.21.4 Enzo Life Sciences Company Profile and Main Business
10.21.5 Enzo Life Sciences Recent Developments
10.22 AssayPro
10.22.1 AssayPro Company Information, Head Office, Market Area and Industry Position
10.22.2 AssayPro HMGB1 Antibody Models, Specifications and Application
10.22.3 AssayPro HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.22.4 AssayPro Company Profile and Main Business
10.22.5 AssayPro Recent Developments
10.23 Cell Signaling Technology
10.23.1 Cell Signaling Technology Company Information, Head Office, Market Area and Industry Position
10.23.2 Cell Signaling Technology HMGB1 Antibody Models, Specifications and Application
10.23.3 Cell Signaling Technology HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.23.4 Cell Signaling Technology Company Profile and Main Business
10.23.5 Cell Signaling Technology Recent Developments
10.24 R and D Systems
10.24.1 R and D Systems Company Information, Head Office, Market Area and Industry Position
10.24.2 R and D Systems HMGB1 Antibody Models, Specifications and Application
10.24.3 R and D Systems HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.24.4 R and D Systems Company Profile and Main Business
10.24.5 R and D Systems Recent Developments
10.25 Aviva Systems Biology
10.25.1 Aviva Systems Biology Company Information, Head Office, Market Area and Industry Position
10.25.2 Aviva Systems Biology HMGB1 Antibody Models, Specifications and Application
10.25.3 Aviva Systems Biology HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.25.4 Aviva Systems Biology Company Profile and Main Business
10.25.5 Aviva Systems Biology Recent Developments
10.26 Beijing Solarbio
10.26.1 Beijing Solarbio Company Information, Head Office, Market Area and Industry Position
10.26.2 Beijing Solarbio HMGB1 Antibody Models, Specifications and Application
10.26.3 Beijing Solarbio HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.26.4 Beijing Solarbio Company Profile and Main Business
10.26.5 Beijing Solarbio Recent Developments
10.27 Jingjie PTM BioLab
10.27.1 Jingjie PTM BioLab Company Information, Head Office, Market Area and Industry Position
10.27.2 Jingjie PTM BioLab HMGB1 Antibody Models, Specifications and Application
10.27.3 Jingjie PTM BioLab HMGB1 Antibody Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.27.4 Jingjie PTM BioLab Company Profile and Main Business
10.27.5 Jingjie PTM BioLab Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
Table 1. HMGB1 Antibody Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. HMGB1 Antibody Market Restraints
Table 3. HMGB1 Antibody Market Trends
Table 4. HMGB1 Antibody Industry Policy
Table 5. Global HMGB1 Antibody Revenue by Company, 2018-2023, US$ million
Table 6. Global HMGB1 Antibody Revenue Market Share by Company, 2018-2023
Table 7. Global HMGB1 Antibody Sales Volume by Company, 2018-2023, (L)
Table 8. Global HMGB1 Antibody Sales Volume Market Share by Company, 2018-2023
Table 9. Global HMGB1 Antibody Price by Company, 2018-2023, (US$/L)
Table 10. Global HMGB1 Antibody Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global HMGB1 Antibody Mergers & Acquisitions, Expansion Plans
Table 12. Global HMGB1 Antibody Manufacturers Product Type
Table 13. China HMGB1 Antibody Revenue by Company, 2018-2023, US$ million
Table 14. China HMGB1 Antibody Revenue Market Share by Company, 2018-2023
Table 15. China HMGB1 Antibody Sales Volume by Company, 2018-2023, (L)
Table 16. China HMGB1 Antibody Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, HMGB1 Antibody Production, Sales, Import and Export, 2018-2029, (L)
Table 18. China HMGB1 Antibody Import & Export Trends
Table 19. Main Sources of China HMGB1 Antibody Import
Table 20. Export Destination of China HMGB1 Antibody
Table 21. Global Headquarters and Manufacturing Base of HMGB1 Antibody Manufacturers
Table 22. Global Major Manufacturers, HMGB1 Antibody Capacity Expansion and Future Plans
Table 23. Global HMGB1 Antibody Production & Forecast by Region, 2018 VS 2022 VS 2029, (L)
Table 24. Global HMGB1 Antibody Production by Region, 2018-2023, (L)
Table 25. Global HMGB1 Antibody Production Forecast by Region, 2023-2029, (L)
Table 26. Global Key Players of HMGB1 Antibody Upstream (Raw Materials)
Table 27. Global HMGB1 Antibody Typical Customers
Table 28. HMGB1 Antibody Typical Distributors
Table 29. By Type, Global HMGB1 Antibody Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global HMGB1 Antibody Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global HMGB1 Antibody Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global HMGB1 Antibody Revenue, 2018-2029, US$ Million
Table 33. By Region, Global HMGB1 Antibody Sales Volume, 2018-2029, (L)
Table 34. By Country, Global HMGB1 Antibody Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global HMGB1 Antibody Revenue, 2018-2029, US$ Million
Table 36. By Country, Global HMGB1 Antibody Revenue Market Share, 2018-2029
Table 37. By Country, Global HMGB1 Antibody Sales Volume, 2018-2029, (L)
Table 38. By Country, Global HMGB1 Antibody Sales Volume Market Share, 2018-2029
Table 39. Merck Company Information, Head Office, Market Area and Industry Position
Table 40. Merck HMGB1 Antibody Models, Specifications and Application
Table 41. Merck HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 42. Merck Company Profile and Main Business
Table 43. Merck Recent Developments
Table 44. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
Table 45. Thermo Fisher Scientific HMGB1 Antibody Models, Specifications and Application
Table 46. Thermo Fisher Scientific HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 47. Thermo Fisher Scientific Company Profile and Main Business
Table 48. Thermo Fisher Scientific Recent Developments
Table 49. Novus Biologicals Company Information, Head Office, Market Area and Industry Position
Table 50. Novus Biologicals HMGB1 Antibody Models, Specifications and Application
Table 51. Novus Biologicals HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 52. Novus Biologicals Company Profile and Main Business
Table 53. Novus Biologicals Recent Developments
Table 54. Abbexa Company Information, Head Office, Market Area and Industry Position
Table 55. Abbexa HMGB1 Antibody Models, Specifications and Application
Table 56. Abbexa HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 57. Abbexa Company Profile and Main Business
Table 58. Abbexa Recent Developments
Table 59. LifeSpan BioSciences Company Information, Head Office, Market Area and Industry Position
Table 60. LifeSpan BioSciences HMGB1 Antibody Models, Specifications and Application
Table 61. LifeSpan BioSciences HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 62. LifeSpan BioSciences Company Profile and Main Business
Table 63. LifeSpan BioSciences Recent Developments
Table 64. GeneTex Company Information, Head Office, Market Area and Industry Position
Table 65. GeneTex HMGB1 Antibody Models, Specifications and Application
Table 66. GeneTex HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 67. GeneTex Company Profile and Main Business
Table 68. GeneTex Recent Developments
Table 69. Bio-Rad Company Information, Head Office, Market Area and Industry Position
Table 70. Bio-Rad HMGB1 Antibody Models, Specifications and Application
Table 71. Bio-Rad HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 72. Bio-Rad Company Profile and Main Business
Table 73. Bio-Rad Recent Developments
Table 74. Bioss Company Information, Head Office, Market Area and Industry Position
Table 75. Bioss HMGB1 Antibody Models, Specifications and Application
Table 76. Bioss HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 77. Bioss Company Profile and Main Business
Table 78. Bioss Recent Developments
Table 79. Chondrex Company Information, Head Office, Market Area and Industry Position
Table 80. Chondrex HMGB1 Antibody Models, Specifications and Application
Table 81. Chondrex HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 82. Chondrex Company Profile and Main Business
Table 83. Chondrex Recent Developments
Table 84. Biorbyt Company Information, Head Office, Market Area and Industry Position
Table 85. Biorbyt HMGB1 Antibody Models, Specifications and Application
Table 86. Biorbyt HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 87. Biorbyt Company Profile and Main Business
Table 88. Biorbyt Recent Developments
Table 89. Abnova Corporation Company Information, Head Office, Market Area and Industry Position
Table 90. Abnova Corporation HMGB1 Antibody Models, Specifications and Application
Table 91. Abnova Corporation HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 92. Abnova Corporation Company Profile and Main Business
Table 93. Abnova Corporation Recent Developments
Table 94. Abeomics Company Information, Head Office, Market Area and Industry Position
Table 95. Abeomics HMGB1 Antibody Models, Specifications and Application
Table 96. Abeomics HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 97. Abeomics Company Profile and Main Business
Table 98. Abeomics Recent Developments
Table 99. Abcam Company Information, Head Office, Market Area and Industry Position
Table 100. Abcam HMGB1 Antibody Models, Specifications and Application
Table 101. Abcam HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 102. Abcam Company Profile and Main Business
Table 103. Abcam Recent Developments
Table 104. RayBiotech Company Information, Head Office, Market Area and Industry Position
Table 105. RayBiotech HMGB1 Antibody Models, Specifications and Application
Table 106. RayBiotech HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 107. RayBiotech Company Profile and Main Business
Table 108. RayBiotech Recent Developments
Table 109. EpiGentek Company Information, Head Office, Market Area and Industry Position
Table 110. EpiGentek HMGB1 Antibody Models, Specifications and Application
Table 111. EpiGentek HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 112. EpiGentek Company Profile and Main Business
Table 113. EpiGentek Recent Developments
Table 114. NSJ Bioreagents Company Information, Head Office, Market Area and Industry Position
Table 115. NSJ Bioreagents HMGB1 Antibody Models, Specifications and Application
Table 116. NSJ Bioreagents HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 117. NSJ Bioreagents Company Profile and Main Business
Table 118. NSJ Bioreagents Recent Developments
Table 119. ProSci Company Information, Head Office, Market Area and Industry Position
Table 120. ProSci HMGB1 Antibody Models, Specifications and Application
Table 121. ProSci HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 122. ProSci Company Profile and Main Business
Table 123. ProSci Recent Developments
Table 124. BioLegend Company Information, Head Office, Market Area and Industry Position
Table 125. BioLegend HMGB1 Antibody Models, Specifications and Application
Table 126. BioLegend HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 127. BioLegend Company Profile and Main Business
Table 128. BioLegend Recent Developments
Table 129. HUABIO Company Information, Head Office, Market Area and Industry Position
Table 130. HUABIO HMGB1 Antibody Models, Specifications and Application
Table 131. HUABIO HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 132. HUABIO Company Profile and Main Business
Table 133. HUABIO Recent Developments
Table 134. Elabscience Biotechnology Company Information, Head Office, Market Area and Industry Position
Table 135. Elabscience Biotechnology HMGB1 Antibody Models, Specifications and Application
Table 136. Elabscience Biotechnology HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 137. Elabscience Biotechnology Company Profile and Main Business
Table 138. Elabscience Biotechnology Recent Developments
Table 139. Enzo Life Sciences Company Information, Head Office, Market Area and Industry Position
Table 140. Enzo Life Sciences HMGB1 Antibody Models, Specifications and Application
Table 141. Enzo Life Sciences HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 142. Enzo Life Sciences Company Profile and Main Business
Table 143. Enzo Life Sciences Recent Developments
Table 144. AssayPro Company Information, Head Office, Market Area and Industry Position
Table 145. AssayPro HMGB1 Antibody Models, Specifications and Application
Table 146. AssayPro HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 147. AssayPro Company Profile and Main Business
Table 148. AssayPro Recent Developments
Table 149. Cell Signaling Technology Company Information, Head Office, Market Area and Industry Position
Table 150. Cell Signaling Technology HMGB1 Antibody Models, Specifications and Application
Table 151. Cell Signaling Technology HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 152. Cell Signaling Technology Company Profile and Main Business
Table 153. Cell Signaling Technology Recent Developments
Table 154. R and D Systems Company Information, Head Office, Market Area and Industry Position
Table 155. R and D Systems HMGB1 Antibody Models, Specifications and Application
Table 156. R and D Systems HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 157. R and D Systems Company Profile and Main Business
Table 158. R and D Systems Recent Developments
Table 159. Aviva Systems Biology Company Information, Head Office, Market Area and Industry Position
Table 160. Aviva Systems Biology HMGB1 Antibody Models, Specifications and Application
Table 161. Aviva Systems Biology HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 162. Aviva Systems Biology Company Profile and Main Business
Table 163. Aviva Systems Biology Recent Developments
Table 164. Beijing Solarbio Company Information, Head Office, Market Area and Industry Position
Table 165. Beijing Solarbio HMGB1 Antibody Models, Specifications and Application
Table 166. Beijing Solarbio HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 167. Beijing Solarbio Company Profile and Main Business
Table 168. Beijing Solarbio Recent Developments
Table 169. Jingjie PTM BioLab Company Information, Head Office, Market Area and Industry Position
Table 170. Jingjie PTM BioLab HMGB1 Antibody Models, Specifications and Application
Table 171. Jingjie PTM BioLab HMGB1 Antibody Sales Volume (L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2018-2023
Table 172. Jingjie PTM BioLab Company Profile and Main Business
Table 173. Jingjie PTM BioLab Recent Developments
List of Figure
Figure 1. HMGB1 Antibody Picture
Figure 2. By Revenue, Global HMGB1 Antibody Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global HMGB1 Antibody Market Size and Forecast, 2018-2029, (L)
Figure 4. Global HMGB1 Antibody Price Trend, 2018-2029, (US$/L)
Figure 5. By Revenue, China HMGB1 Antibody Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China HMGB1 Antibody Market Size and Forecast, 2018-2029, (L)
Figure 7. China HMGB1 Antibody Price Trend, 2018-2029 (US$/L)
Figure 8. By Revenue, China HMGB1 Antibody Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China HMGB1 Antibody Share of Global Market, 2018-2029
Figure 10. Global HMGB1 Antibody Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global HMGB1 Antibody Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China HMGB1 Antibody Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China HMGB1 Antibody Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China HMGB1 Antibody Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of HMGB1 Antibody Domestic VS Export, 2022
Figure 16. Global HMGB1 Antibody Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global HMGB1 Antibody Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global HMGB1 Antibody Production Market Share & Forecast by Region, 2018-2029
Figure 19. HMGB1 Antibody Industry Chain
Figure 20. HMGB1 Antibody Procurement Model
Figure 21. HMGB1 Antibody Sales Model
Figure 22. HMGB1 Antibody Sales Channels, Direct Sales and Distribution
Figure 23. Monoclonal
Figure 24. Polyclonal
Figure 25. By Type, Global HMGB1 Antibody Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global HMGB1 Antibody Revenue Market Share, 2018-2029
Figure 27. By Type, Global HMGB1 Antibody Sales Volume, 2018-2029, (L)
Figure 28. By Type, Global HMGB1 Antibody Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global HMGB1 Antibody Price, 2018-2029, (US$/L)
Figure 30. Immunochemistry (IHC)
Figure 31. Immunofluorescence (IF)
Figure 32. Western Blot (WB)
Figure 33. Immunocytochemistry (ICC)
Figure 34. ELISA
Figure 35. Others
Figure 36. By Application, Global HMGB1 Antibody Revenue, 2018-2029, US$ Million
Figure 37. By Application, Global HMGB1 Antibody Revenue Market Share, 2018-2029
Figure 38. By Application, Global HMGB1 Antibody Sales Volume, 2018-2029, (L)
Figure 39. By Application, Global HMGB1 Antibody Sales Volume Market Share, 2018-2029
Figure 40. By Application, Global HMGB1 Antibody Price, 2018-2029, (US$/L)
Figure 41. By Region, Global HMGB1 Antibody Revenue Market Share, 2018-2029
Figure 42. By Region, Global HMGB1 Antibody Sales Volume Market Share, 2018-2029
Figure 43. North America HMGB1 Antibody Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, North America HMGB1 Antibody Revenue Market Share, 2022
Figure 45. Europe HMGB1 Antibody Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, Europe HMGB1 Antibody Revenue Market Share, 2022
Figure 47. Asia Pacific HMGB1 Antibody Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country/Region, Asia Pacific HMGB1 Antibody Revenue Market Share, 2022
Figure 49. South America HMGB1 Antibody Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. By Country, South America HMGB1 Antibody Revenue Market Share, 2022
Figure 51. Middle East & Africa HMGB1 Antibody Revenue & Forecasts, 2018-2029, US$ Million
Figure 52. U.S. HMGB1 Antibody Sales Volume, 2018-2029, (L)
Figure 53. By Company, U.S. HMGB1 Antibody Market Share, 2022
Figure 54. By Type, U.S. HMGB1 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 55. By Application, U.S. HMGB1 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 56. Europe HMGB1 Antibody Sales Volume, 2018-2029, (L)
Figure 57. By Company, Europe HMGB1 Antibody Market Share, 2022
Figure 58. By Type, Europe HMGB1 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 59. By Application, Europe HMGB1 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 60. China HMGB1 Antibody Sales Volume, 2018-2029, (L)
Figure 61. By Company, China HMGB1 Antibody Market Share, 2022
Figure 62. By Type, China HMGB1 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 63. By Application, China HMGB1 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 64. Japan HMGB1 Antibody Sales Volume, 2018-2029, (L)
Figure 65. By Company, Japan HMGB1 Antibody Market Share, 2022
Figure 66. By Type, Japan HMGB1 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 67. By Application, Japan HMGB1 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 68. South Korea HMGB1 Antibody Sales Volume, 2018-2029, (L)
Figure 69. By Company, South Korea HMGB1 Antibody Market Share, 2022
Figure 70. By Type, South Korea HMGB1 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 71. By Application, South Korea HMGB1 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 72. Southeast Asia HMGB1 Antibody Sales Volume, 2018-2029, (L)
Figure 73. By Company, Southeast Asia HMGB1 Antibody Market Share, 2022
Figure 74. By Type, Southeast Asia HMGB1 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 75. By Application, Southeast Asia HMGB1 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 76. India HMGB1 Antibody Sales Volume, 2018-2029, (L)
Figure 77. By Company, India HMGB1 Antibody Market Share, 2022
Figure 78. By Type, India HMGB1 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 79. By Application, India HMGB1 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 80. Middle East & Asia HMGB1 Antibody Sales Volume, 2018-2029, (L)
Figure 81. By Company, Middle East & Asia HMGB1 Antibody Market Share, 2022
Figure 82. By Type, Middle East & Asia HMGB1 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 83. By Application, Middle East & Asia HMGB1 Antibody Sales Volume Market Share, 2022 VS 2029
Figure 84. Research Methodology
Figure 85. Breakdown of Primary Interviews
Figure 86. Bottom-up Approaches
Figure 87. Top-down Approaches
Research Methodology:
Global HMGB1 Antibody Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|